Why is Neuland Labs. falling/rising?

As of 28-Jul, Neuland Laboratories Ltd is experiencing a decline in its stock price, currently at 13,824.00, reflecting a decrease of 66.0 points or 0.48%. The stock has underperformed its sector by 0.56% today, following a trend reversal after two consecutive days of gains. Although the stock has shown strong performance over the past year with a return of 65.04%, it has recently faced challenges, including a significant drop in net sales of 17.5% and negative results for the last three consecutive quarters. Additionally, the stock's delivery volume has decreased by 33.65% against the five-day average, indicating falling investor participation. Despite a low Debt to EBITDA ratio of 0.57 and high institutional holdings at 33.66%, the stock's valuation appears expensive with a Price to Book Value of 11.6, which may deter some investors.
In the broader market context, Neuland Laboratories Ltd has underperformed the Sensex over the past week, with a decline of 2.51% compared to the benchmark's drop of 1.59%. While the stock has shown strong returns over longer periods, such as 989.45% over three years, the recent negative financial results and declining sales may be contributing to investor caution. The overall market sentiment, coupled with the company's recent performance, suggests that investors are reacting to the negative financial indicators, leading to the current decline in stock price.